Style
Aggressive GrowthTurnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc(PTGX) | 2,449,183 | $345.1M | 45.30% |
| 2 | Nanobiotix(NBTX) | 5,623,816 | $175.2M | 23.01% |
| 3 | Meiragtx Hldgs PLC(MGTX) | 6,641,064 | $73.1M | 9.59% |
| 4 | Rapport Therapeutics Inc(RAPP) | 1,784,517 | $60.0M | 7.87% |
| 5 | Contineum Therapeutics Inc(CTNM) | 1,979,173 | $26.6M | 3.49% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 87.28% | 87.41% | +0.13% |
| Unclassified | 12.72% | 12.59% | -0.13% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Cerebras Systems Inc(CBRS) |
| 128,649 |
| $22.9M |
| 3.00% |
| 7 | Xencor Inc(XNCR) | 748,062 | $18.7M | 2.45% |
| 8 | Legend Biotech Corp(LEGN) | 814,586 | $16.2M | 2.13% |
| 9 | Fate Therapeutics Inc(FATE) | 3,379,064 | $8.0M | 1.05% |
| 10 | Cvrx Inc(CVRX) | 4,024,861 | $7.0M | 0.92% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Mid Cap | 40.54% | 47.43% | +6.89% |
| Small Cap | 42.99% | 37.98% | -5.01% |
| Unclassified | 12.72% | 12.59% | -0.13% |
| Micro Cap | 3.76% | 2% | -1.76% |
Quarter-over-quarter position changes